Lung microbial dysregulation and TNF inhibition contribute to worsened nontuberculous mycobacterial lung disease

Key Points

• Worsening lung disease severity is linked to both microbial dysregulation and TNF inhibition, which may exacerbate patient outcomes.
• Data indicate that patients with higher TNF levels experience a greater degree of lung impairment tied to nontuberculous mycobacterial infections.
• Analysis of lung samples shows a correlation between shifts in microbial populations and dysregulated immune responses affecting lung health.
• Findings support the idea that targeting TNF pathways could potentially improve management of nontuberculous mycobacterial lung disease.